A clinical solution to antimicrobial resistance in community-acquired pneumonia: Narrowing the spectrum of antimicrobial therapy

Archives of Internal Medicine

Volumn 171, Issue 2, 2011, Pages 172-173

  Yu, Victor L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIVIRUS AGENT; BACTERIAL ANTIGEN; CEPHALOSPORIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ANTIVIRAL THERAPY; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; INFLUENZA; LEGIONNAIRE DISEASE; NONHUMAN; NOTE; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; URINALYSIS; VIRUS IDENTIFICATION; VIRUS PNEUMONIA;

ANTIGENS, BACTERIAL; CEPHALOSPORINS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; PENICILLINS; PNEUMONIA, PNEUMOCOCCAL; POINT-OF-CARE SYSTEMS; QUINOLONES; STREPTOCOCCUS PNEUMONIAE;

EID: 79251538050     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.474     Document Type: Note

References (9)

1. Yu VL, Stout JE. Rapid diagnostic testing for community-acquired pneumonia: can innovative technology for clinical microbiology be exploited? Chest. 2009;136(6):1618-1621.
2. Johansson NKM, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010;50(2):202-209.
3. Leggieri N, Rida A, François P, Schrenzel J. Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside. Curr Opin Infect Dis. 2010;23(4):311-319.
4. Chiou CC. Does penicillin remain the drug of choice for pneumococcal pneumonia in view of emerging in vitro resistance? Clin Infect Dis. 2006;42(2): 234-237.
5. Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis. In press.
6. Weatherall C, Paoloni R, Gottlieb T. Point-of-care urinary pneumococcal antigen test in the emergency department for community acquired pneumonia. Emerg Med J. 2008;25(3):144-148. (Pubitemid 351351105)
7. Kobashi Y, Yoshida K, Miyashita N, Niki Y, Matsushima T. Evaluating the use of a Streptococcus pneumoniae urinary antigen detection kit for the management of community-acquired pneumonia in Japan. Respiration. 2007; 74(4):387-393. (Pubitemid 47093150)
8. Falguera M, Ruiz-González A, Schoenenberger JA, et al. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Thorax. 2010;65(2):101-106.
9. Guchev IA, Yu VL, Sinopalnikov A, Klochkov OI, Kozlov RS, Stratchounski LS. Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy. Clin Infect Dis. 2005;40(11):1608-1616. (Pubitemid 40720811)